Ainos Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
AIMD Over the counter 8731 http://www.ainos.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ainos Inc

Ainos Announces Positive Results from Preclinical Studies of Its Low-dose Oral Interferon Formulation Against COVID-19 - Jun 27th, 2022 11:00 am
Ainos COVID-19 Antigen Self-Test Receives Approval for Sale in Taiwan - Jun 21st, 2022 11:00 am
Ainos Announces Strategic Relationship with InnoPharmax to Jointly Develop Combined Oral Therapy for Coronavirus Infection - Dec 7th, 2021 11:55 pm
Ainos SRNA Research Initiative Announces Milestones for mRNA Vaccine Development - Nov 3rd, 2021 4:00 pm
Ainos Elects Ms. Hui-Lan (Celia) Wu as CFO, Lawrence K. Lin as Executive Vice President of Operations, and Other Key Executives - Aug 16th, 2021 1:23 pm